Yadlowsky S, Hayward RA, Sussman JB, McClelland RL, Min YI, Basu S. Clinical implications of revised pooled cohort equations for estimating atherosclerotic cardiovascular disease risk. Ann Intern Med 2018;169:20-9. [Ref.ID 102647]

Mir de Francia R. Los fabricantes de opioides fijan a España como nuevo mercado. eldiario.es 2018:1. [Ref.ID 102452]

Chobanian AV. Hypertension in 2017- What is the right target?. JAMA 2017;317:579-80. [Ref.ID 101415]

Tricco AC, Zarin W, Lillie E, Pham B, Straus SE. Utility of social media and crowd-sourced data for pharmacovigilance: a scoping review protocol. BMJ Open 2017;7:e013474. [Ref.ID 101354]

Abraha I, Cherubini A, Cozzolino F, De Florio R, Luchetta ML, Rimland JM, Folletti I, Marchesi M, Germani A, Orso M, Eusebi P, Montedori A. Deviation from intention to treat analysis in randomised trials and treatment effect estimates: meta-epidemiological study. BMJ 2015;350:h2445. [Ref.ID 99147]

The DISCO study group. Subgroup analyses in randomised controlled trials: cohort study on trial protocols and journal publications. BMJ 2014;349:g4539. [Ref.ID 98144]

Holloway KA, Henry D. WHO essential medicines policies and use in developing and transitional countries: an analysis of reported policy implementation and medicines use surveys . PLOS ONE 2014:16 de septiembre. [Ref.ID 98019]

Kasenda B, von Elm E, You J, Blümle A, Tomonaga Y, Saccilotto R, Amstutz A, Bengough T, Meerpohl JJ, Stegert M, Tikkinen KAO, Neumann I, Carrasco-Labra A, Faulhaber M, Mulla SM, Mertz D, Akl EA, Bassler D, Busse JW, Ferreira-González I, Lamontagne F, Nordmann A, Gloy V, Raatz H, Moja L, Rosenthal R, Ebrahim S, Schandelmaier S, Xin S, Vandvik PO, Johnston BC, Walter MA, Burnand B, Schwenkglenks M, Hemkens LG, Bucher HC, Guyatt GH, Briel M. Prevalence, characteristics, and publication of discontinued randomized trials . JAMA 2014;311:1045-52. [Ref.ID 97229]

Rennie D, Flanagin A. Research on peer review and biomedical publication. Furthering the quest to improve the quality of reporting. JAMA 2014;311:1019-20. [Ref.ID 97228]

Barron H, Rosenblatt M. Access to patient-level trial data. N Engl J Med 2014;370:485-6. [Ref.ID 97072]

Ferri M, Abdallah K. Preparing for responsible sharing of clinical trial data. N Engl J Med 2014;370:484-5. [Ref.ID 97071]

Friedman AB. Preparing for responsible sharing of clinical trial data. N Engl J Med 2014;370:484. [Ref.ID 97070]

Reade MC, Finfer S. Sedation and delirium in the intensive care unit. N Engl J Med 2014;370:444-54. [Ref.ID 97065]

Frieden TR, Coleman King SM, Wright JS. Protocol-based treatment of hypertension: a critical step on the pathway to progress. JAMA 2014;311:21-2. [Ref.ID 97031]

Sanfélix-Genovés J, Catalá-López F, Sanfélix-Gimeno G, Hurtado I, Baixauli C, Peiró S. Variabilidad en las recomendaciones para el abordaje clínico de la osteoporosis. Med Clin (Barc) 2014;142:15-22. [Ref.ID 97016]

Saquib N, Saquib J, Ioannidis JPA. Practices and impact of primary outcome adjustment in randomized controlled trials: meta-epidemiologic study. BMJ 2013;347:15. [Ref.ID 96145]

López A, Costa J. Guía de consenso sobre los contenidos de los protocolos de ensayos clínicos. Med Clin (Barc) 2013;141:161-2. [Ref.ID 96060]

Toussaint B. EU clinical trial regulation. Lancet 2013;381:1719-20. [Ref.ID 95444]

Clark T, Berger U, Mansmann U. Sample size determinations in original research protocols for randomised clinical trials submitted to UK research ethics committees: review. BMJ 2013;346:13. [Ref.ID 95411]

Chan A-W, Telzlaff JM, Altman DG, Laupacis A, Gotzche PC, Krieza-Jeric K, Hrobjartsson A, Mann H, Dickersin K, Berlin JA, Doré CJ, Parulekar WR, Summerskill WSM, Groves T, Schulz KF, Sox HC, Rockhold FW, Rennie D, Moher D. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med 2013;158:200-7. [Ref.ID 94901]